Additional data has been included in sections:
- 4.4 4.4 - Histological grading of non-muscle-invasive bladder urothelial carcinomas
- 5.11.1 - Photodynamic diagnosis (fluorescence cystoscopy);
- 5.12 - Second resection;
- 7.2.1.3.2 - Device-assisted intravesical chemotherapy.
New recommendations have been added to:
- Section 5.9 - Summary of evidence and guidelines for the primary assessment of non-muscle-invasive bladder cancer
| Recommendations | Strength rating |
| In men, use flexible cystoscope, if available. | Strong |
| Describe all macroscopic features of the tumour (site, size, number and appearance) and mucosal abnormalities during cystoscopy. Use a bladder diagram (Figure 5.1). | Strong
|
| Use the Paris system for cytology reporting. | Strong |
- Section 5.14 - Summary of evidence and guidelines for transurethral resection of the bladder, biopsies and pathology report
| Recommendations | Strength rating |
| Performance of individual steps | |
| Use methods to improve tumour visualization (FC, NBI) during TURB, if available. | Weak |